173 related articles for article (PubMed ID: 18295506)
1. MeCP2 mutation causes distinguishable phases of acute and chronic defects in synaptogenesis and maintenance, respectively.
Palmer A; Qayumi J; Ronnett G
Mol Cell Neurosci; 2008 Apr; 37(4):794-807. PubMed ID: 18295506
[TBL] [Abstract][Full Text] [Related]
2. The transcriptional repressor Mecp2 regulates terminal neuronal differentiation.
Matarazzo V; Cohen D; Palmer AM; Simpson PJ; Khokhar B; Pan SJ; Ronnett GV
Mol Cell Neurosci; 2004 Sep; 27(1):44-58. PubMed ID: 15345242
[TBL] [Abstract][Full Text] [Related]
3. MeCP2 expression and function during brain development: implications for Rett syndrome's pathogenesis and clinical evolution.
Kaufmann WE; Johnston MV; Blue ME
Brain Dev; 2005 Nov; 27 Suppl 1():S77-S87. PubMed ID: 16182491
[TBL] [Abstract][Full Text] [Related]
4. Methyl CpG-binding protein 2 (a mutation of which causes Rett syndrome) directly regulates insulin-like growth factor binding protein 3 in mouse and human brains.
Itoh M; Ide S; Takashima S; Kudo S; Nomura Y; Segawa M; Kubota T; Mori H; Tanaka S; Horie H; Tanabe Y; Goto Y
J Neuropathol Exp Neurol; 2007 Feb; 66(2):117-23. PubMed ID: 17278996
[TBL] [Abstract][Full Text] [Related]
5. The story of Rett syndrome: from clinic to neurobiology.
Chahrour M; Zoghbi HY
Neuron; 2007 Nov; 56(3):422-37. PubMed ID: 17988628
[TBL] [Abstract][Full Text] [Related]
6. Neural development of methyl-CpG-binding protein 2 null embryonic stem cells: a system for studying Rett syndrome.
Okabe Y; Kusaga A; Takahashi T; Mitsumasu C; Murai Y; Tanaka E; Higashi H; Matsuishi T; Kosai K
Brain Res; 2010 Nov; 1360():17-27. PubMed ID: 20816763
[TBL] [Abstract][Full Text] [Related]
7. Cell-specific expression of wild-type MeCP2 in mouse models of Rett syndrome yields insight about pathogenesis.
Alvarez-Saavedra M; Sáez MA; Kang D; Zoghbi HY; Young JI
Hum Mol Genet; 2007 Oct; 16(19):2315-25. PubMed ID: 17635839
[TBL] [Abstract][Full Text] [Related]
8. Deciphering Rett syndrome with mouse genetics, epigenomics, and human neurons.
Tao J; Wu H; Sun YE
Int Rev Neurobiol; 2009; 89():147-60. PubMed ID: 19900619
[TBL] [Abstract][Full Text] [Related]
9. Rett syndrome: from the gene to the disease.
Matijevic T; Knezevic J; Slavica M; Pavelic J
Eur Neurol; 2009; 61(1):3-10. PubMed ID: 18948693
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of disease: neurogenetics of MeCP2 deficiency.
Francke U
Nat Clin Pract Neurol; 2006 Apr; 2(4):212-21. PubMed ID: 16932552
[TBL] [Abstract][Full Text] [Related]
11. Early defects of GABAergic synapses in the brain stem of a MeCP2 mouse model of Rett syndrome.
Medrihan L; Tantalaki E; Aramuni G; Sargsyan V; Dudanova I; Missler M; Zhang W
J Neurophysiol; 2008 Jan; 99(1):112-21. PubMed ID: 18032561
[TBL] [Abstract][Full Text] [Related]
12. A methyl-CpG-binding protein 2-enhanced green fluorescent protein reporter mouse model provides a new tool for studying the neuronal basis of Rett syndrome.
Schmid RS; Tsujimoto N; Qu Q; Lei H; Li E; Chen T; Blaustein CS
Neuroreport; 2008 Mar; 19(4):393-8. PubMed ID: 18287934
[TBL] [Abstract][Full Text] [Related]
13. Behavioral and anatomical abnormalities in Mecp2 mutant mice: a model for Rett syndrome.
Stearns NA; Schaevitz LR; Bowling H; Nag N; Berger UV; Berger-Sweeney J
Neuroscience; 2007 May; 146(3):907-21. PubMed ID: 17383101
[TBL] [Abstract][Full Text] [Related]
14. Postnatal loss of methyl-CpG binding protein 2 in the forebrain is sufficient to mediate behavioral aspects of Rett syndrome in mice.
Gemelli T; Berton O; Nelson ED; Perrotti LI; Jaenisch R; Monteggia LM
Biol Psychiatry; 2006 Mar; 59(5):468-76. PubMed ID: 16199017
[TBL] [Abstract][Full Text] [Related]
15. Mouse models of Rett syndrome: from behavioural phenotyping to preclinical evaluation of new therapeutic approaches.
Ricceri L; De Filippis B; Laviola G
Behav Pharmacol; 2008 Sep; 19(5-6):501-17. PubMed ID: 18690105
[TBL] [Abstract][Full Text] [Related]
16. Clinical profiles of four patients with Rett syndrome carrying a novel exon 1 mutation or genomic rearrangement in the MECP2 gene.
Bartholdi D; Klein A; Weissert M; Koenig N; Baumer A; Boltshauser E; Schinzel A; Berger W; Mátyás G
Clin Genet; 2006 Apr; 69(4):319-26. PubMed ID: 16630165
[TBL] [Abstract][Full Text] [Related]
17. Spectrum and distribution of MECP2 mutations in 424 Rett syndrome patients: a molecular update.
Philippe C; Villard L; De Roux N; Raynaud M; Bonnefond JP; Pasquier L; Lesca G; Mancini J; Jonveaux P; Moncla A; Chelly J; Bienvenu T
Eur J Med Genet; 2006; 49(1):9-18. PubMed ID: 16473305
[TBL] [Abstract][Full Text] [Related]
18. Evidence for both neuronal cell autonomous and nonautonomous effects of methyl-CpG-binding protein 2 in the cerebral cortex of female mice with Mecp2 mutation.
Belichenko NP; Belichenko PV; Mobley WC
Neurobiol Dis; 2009 Apr; 34(1):71-7. PubMed ID: 19167498
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of brain morphology in Mecp2 mutant mouse models of Rett syndrome.
Belichenko NP; Belichenko PV; Li HH; Mobley WC; Francke U
J Comp Neurol; 2008 May; 508(1):184-95. PubMed ID: 18306326
[TBL] [Abstract][Full Text] [Related]
20. Widespread changes in dendritic and axonal morphology in Mecp2-mutant mouse models of Rett syndrome: evidence for disruption of neuronal networks.
Belichenko PV; Wright EE; Belichenko NP; Masliah E; Li HH; Mobley WC; Francke U
J Comp Neurol; 2009 May; 514(3):240-58. PubMed ID: 19296534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
